Jan. 26, 2022 - GoCreate is using its equipment and expertise to build form work for the center concrete pier of the Promise Bridge. GoCreate staff and Wichita State students will machine 30 blocks of foam, each 4 feet by 3 feet by 8 feet, that will be used by Dondlinger Construction.
Six Wichita State University teams were selected as semi-finalists in the university’s sixth annual Koch Innovation Challenge Angel Round on December 3. Those six teams of Wichita State students advance to the Grand Champion competition in May.
Jan. 20, 2022 — The Alfred P. Sloan Foundation has awarded a grant of $243,922 to a Wichita State University researcher for his work on an app that will allow people who are visually impaired to read comic books, graphic novels and other digitized graphic materials on their devices.
Jan. 18, 2022 — Wichita State’s Molecular Diagnostics Lab (MDL) is open and continues to process thousands of COVID tests with 24-hour results. However, the lab has indefinitely suspended its COVID test collection service.
Dec. 9, 2021 -- Khalid Raza has never forgotten his Shocker roots. Now the chief executive officer of Graphiant, a next-generation networking technology company based in San Francisco, Raza’s first independent start-up began in 1992 when he was working as a graduate assistant at Wichita State University.
Dec. 8, 2021 — Wichita State University’s Diversity, Equity and Inclusion Plan (DEI) includes efforts to promote student success, increase sponsored research funding for diversity and inclusive excellence, and empower the campus community to create a culture and experience that meets its ever-changing needs.
Dec. 7, 2021 – The College of Health Professions (CHP) has initiated a major expansion to the its clinical simulation capabilities. Students across the CHP’s clinical degree programs will have increased exposure to high-tech robotic simulated patients in preparation for treating humans.
Dec. 2, 2021 — In an effort to meet community needs, Wichita State University’s Molecular Diagnostics Lab (MDL) has developed a test to detect all three viruses — RSV, influenza and COVID-19 (RIC) — from one nasal swab. The RIC test is available to all individuals and partners who test via the MDL.